🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety of the GL-ONC1 vaccinia vir...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-01
Trial ID
NCT01766739
Treatments Being Tested
GL-ONC1 expanded access is for patients who are ineligible for an ongoing G...
Status
No Longer Available
Location
Florida Hospital Cancer Institute
Start Date
TBD
Trial ID
NCT03420430
Treatments Being Tested
The OnPrime study is a multi-center, randomized open-label phase 3 study ev...
Status
Recruiting
Location
The University of South Alabama, Mitchell Cancer Institute
Start Date
2022-08-31
Trial ID
NCT05281471
The purpose of this study is to determine the safety and tolerability of GL...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2012-04
Trial ID
NCT01584284
Treatments Being Tested
The main purpose of this study is to determine whether, GL-ONC1, an Oncolyt...
Status
Completed
Location
Royal Marsden Hospital
Start Date
2008-11
Trial ID
NCT00794131
Treatments Being Tested
The purpose of this study is to evaluate the safety of the investigational ...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2016-03-25
Trial ID
NCT02714374
Treatments Being Tested
The purpose of this study is to determine whether GL-ONC1, an attenuated va...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2012-02
Trial ID
NCT01443260
Treatments Being Tested